Key Takeaways Proposed 0.09% Medicare Advantage rate hike for 2027 triggered sharp sell-offs in major U.S. health insurers.Humana slid 13% as flat reimbursement rates threaten margins amid rising administrative costs.Diversified ETFs like VHT balance insurer exposure with strength in pharma and biotech leaders.The Trump administration has sent shockwaves through the healthcare sector by proposing nearly flat reimbursement rates for Medicare Advantage (MA) plans for 2027. Announced on Jan. 26, 2026, the prop ...